Founded: October 1933
Founded: October 1970
Branch established: April 1979
Founded: March 1984
Founded: June 1986
1990
Established a Special Products Development Department within Kato Fattō Co., Ltd. (formerly Pailax Co., Ltd.) in Heisei 2 (1990).
Founded: October 1993
October 1995: Established the Medical Device Division within Pioneer Labs Inc.
Established a Medical Devices Division within Pailax Co., Ltd. in October Heisei 7 (1995).
September 1996: Established a Technical Center in Kariya-cho, Hodogaya-ku, Yokohama City, Kanagawa Prefecture.
September 1996: Produced and OEM supplied guide wires used in cardiac therapy.
Produced and OEM supplied guide wires for cardiac treatment in September Heisei 8 (1996).
Established a Technical Center in Kajiwa-cho, Hodogaya-ku, Yokohama City, Kanagawa Prefecture in September Heisei 8 (1996).
Founded: April 1997
Founded: October 1998
Company establishment
April 1999: Spin-off the medical device sector and established Pioneer Labs Medical Devices Inc.
Company established: April 1, 1999
Spun off the medical device field and established Pailax Medical Devices Co., Ltd. in April Heisei 11 (1999).
April 2009: Acquired all shares of Solution Inc.
Acquired all shares of Solution Co., Ltd. in April Heise 21 (2009).
April 2010: Absorbed Solution Inc.
Absorbed Solution Co., Ltd. in April Heise 22 (2010).
October 2010: Launched the Endoscopy Group selling instruments for endoscopic treatment.
Established Endoscopy Group selling endoscopic treatment instruments in October Heise 22 (2010).
February 2015: Completed a new factory dedicated to medical device manufacturing, Yokohama Office, in Kamiya-cho, Totsuka-ku, Yokohama City, Kanagawa Prefecture.
Completed a new factory dedicated to medical device manufacturing, Yokohama Office, in Kajiya-cho, Totsuka-ku, Yokohama City, Kanagawa Prefecture in February Heise 27 (2015).
September 2018: Moved the development department to the Yokohama Office.
(2018) : September : Development department moved to Yokohama office
(2023) : January : Obtained Environmental Management System (ISO14001) (valid for 3 years from Jan 25)
Obtained ISO14001 Environmental Management System for 3 years from January 25, Reiwa 5 (2023).
Obtained 'Eru Boshi' (3rd stage) certification as an excellent company under the Women’s Empowerment Promotion Act in March Reiwa 6 (2024).
(2024) : March : Obtained excellent company certification under the Act on Promotion of Women's Participation "Eru Boshi (3rd stage)"
Pailax will participate in the 112th Annual Meeting of the Japanese Society of Gastrointestinal Endoscopy (JDDW2026 Kobe), held at the Kobe International Exhibition Center from November 5-7, 2026, by exhibiting equipment. On November 6, we will co-host Breakfast Seminar 14, covering an update on the clinical outcomes of the ELLA-BD Stent PX for refractory benign esophageal strictures.
Pioneer Labs Inc. will exhibit equipment at the 62nd Japanese Hepatobiliary Society Academic Conference, held at Light Cube Utsunomiya on October 16-17, 2026. On October 16, it will co-host Luncheon Seminar 5, delivering a lecture on biliary treatment using RealMaster and guidewire strategies for hilar biliary strictures.
On September 30, 2026 (Wednesday) after 2:00 PM, shipments will be halted due to inventory work. Orders received by 2:00 PM will be shipped on the same day, and those received after 2:00 PM will be shipped on the next business day, October 1. For inquiries, please contact the Sales General Affairs Department.
Piolax Medical Devices, Inc. announced that its biodegradable esophageal stent, ELLA-BD Stent PX, is now available under Japan’s health insurance system. Developed as a new treatment option for refractory benign esophageal strictures, the stent became eligible for coverage on September 1, 2026. The company will continue providing useful medical devices to patients and healthcare professionals, contributing to improved medical care and quality of life.
This Yokohama City-sponsored event for children will feature a program allowing elementary school students to experience medical equipment.
Piolax, Inc. has received Kurumin certification, which recognizes companies for their efforts under Japan's Act on Advancement of Measures to Support Raising Next-Generation Children. The company will continue supporting work-life balance and building a workplace where employees can work with peace of mind.
Piorax Co., Ltd. has established a research and development base in Kobe Medical Industry City to develop minimally invasive medical devices utilizing vascular treatment and endoscopic diagnostic technologies.
Piorax Medical Devices Co., Ltd. obtained pharmaceutical approval for the identification marker "Identification Marker PX" for lung resection support on April 24, 2026.
Piorax Medical Devices Co., Ltd. will hold a co-sponsored seminar and corporate exhibition at the 43rd Annual Meeting of the Japanese Society of Respiratory Surgery.
At the JGES2026 General Assembly to be held at Pacifico Yokohama from May 8 to 10, 2026, co-hosted seminars and equipment exhibitions will be held. The satellite seminar is scheduled to discuss practical approaches to difficult cases.